Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope

被引:0
|
作者
Christopher O. Barnes
Harry B. Gristick
Natalia T. Freund
Amelia Escolano
Artem Y. Lyubimov
Harald Hartweger
Anthony P. West
Aina E. Cohen
Michel C. Nussenzweig
Pamela J. Bjorkman
机构
[1] California Institute of Technology,Division of Biology and Biological Engineering
[2] The Rockefeller University,Laboratory of Molecular Immunology
[3] Stanford Synchrotron Radiation Lightsource,Howard Hughes Medical Institute
[4] The Rockefeller University,Department of Clinical Immunology and Microbiology, Sackler Faculty of Medicine
[5] Tel Aviv University,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Broadly neutralizing antibodies (bNAbs) isolated from HIV-1-infected individuals inform HIV-1 vaccine design efforts. Developing bNAbs with increased efficacy requires understanding how antibodies interact with the native oligomannose and complex-type N-glycan shield that hides most protein epitopes on HIV-1 envelope (Env). Here we present crystal structures, including a 3.8-Å X-ray free electron laser dataset, of natively glycosylated Env trimers complexed with BG18, the most potent V3/N332gp120 glycan-targeting bNAb reported to date. Our structures show conserved contacts mediated by common D gene-encoded residues with the N332gp120 glycan and the gp120 GDIR peptide motif, but a distinct Env-binding orientation relative to PGT121/10-1074 bNAbs. BG18’s binding orientation provides additional contacts with N392gp120 and N386gp120 glycans near the V3-loop base and engages protein components of the V1-loop. The BG18-natively-glycosylated Env structures facilitate understanding of bNAb–glycan interactions critical for using V3/N332gp120 bNAbs therapeutically and targeting their epitope for immunogen design.
引用
收藏
相关论文
共 50 条
  • [21] V5 region in the HIV-1 envelope glycoprotein determines viral sensitivity to the broadly neutralizing monoclonal antibody VRC01
    D Guo
    X Shi
    K Arledge
    D Song
    L Jiang
    L Fu
    S Zhang
    X Wang
    L Zhang
    Retrovirology, 9 (Suppl 2)
  • [22] Alternative substitutions of N332 in HIV-1AD8 gp120 differentially affect envelope glycoprotein function and viral sensitivity to broadly neutralizing antibodies targeting the V3-glycan
    Jeffy, Jeffy
    Parthasarathy, Durgadevi
    Ahmed, Shamim
    Cervera-Benet, Hector
    Xiong, Ulahn
    Harris, Miranda
    Mazurov, Dmitriy
    Pickthorn, Stephanie
    Herschhorn, Alon
    MBIO, 2024, 15 (04):
  • [23] V1 Loop Length Limits Neutralization of HIV-1 Clade C Primary Viruses by Broadly Neutralizing Antibodies Targeting the V3 Glycan
    Deshpande, Suprit
    Patil, Shilpa
    Kumar, Rajesh
    Hermanus, Tandile
    Murugavel, Kailapuri. G.
    Srikrishnan, Aylur K.
    Solomon, Suniti
    Morris, Lynn
    Bhattacharya, Jayanta
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 : 145 - 145
  • [24] Elicitation of broadly reactive antibodies against glycan-modulated neutralizing V3 epitopes of HIV-1 by immune complex vaccines
    Kumar, Rajnish
    Tuen, Michael
    Liu, Jianping
    Nadas, Arthur
    Pan, Ruimin
    Kong, Xiangpeng
    Hioe, Catarina E.
    VACCINE, 2013, 31 (46) : 5413 - 5421
  • [25] HIV-1 Coreceptor Usage and Variable Loop Contact Impact V3 Loop Broadly Neutralizing Antibody Susceptibility
    Registre, Ludy
    Moreau, Yvetane
    Ataca, Sila Toksoz
    Pulukuri, Surya
    Henrich, Timothy J.
    Lin, Nina
    Sagar, Manish
    JOURNAL OF VIROLOGY, 2020, 94 (02)
  • [26] Stabilization of the V2 loop improves the presentation of V2 loop-associated broadly neutralizing antibody epitopes on HIV-1 envelope trimers
    de Taeye, Steven W.
    Go, Eden P.
    Sliepen, Kwinten
    de la Pena, Alba Torrents
    Badal, Kimberly
    Medina-Ramirez, Max
    Lee, Wen-Hsin
    Desaire, Heather
    Wilson, Ian A.
    Moore, John P.
    Ward, Andrew B.
    Sanders, Rogier W.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (14) : 5616 - 5631
  • [27] Functional and Structural Characterization of Human V3-Specific Monoclonal Antibody 2424 with Neutralizing Activity against HIV-1 JRFL
    Kumar, Rajnish
    Pan, Ruimin
    Upadhyay, Chitra
    Mayr, Luzia
    Cohen, Sandra
    Wang, Xiao-Hong
    Balasubramanian, Preetha
    Nadas, Arthur
    Seaman, Michael S.
    Zolla-Pazner, Susan
    Gorny, Miroslaw K.
    Kong, Xiang-Peng
    Hioe, Catarina E.
    JOURNAL OF VIROLOGY, 2015, 89 (17) : 9090 - 9102
  • [28] Trimeric Glycosylphosphatidylinositol-Anchored HCDR3 of Broadly Neutralizing Antibody PG16 Is a Potent HIV-1 Entry Inhibitor
    Liu, Lihong
    Wang, Weiming
    Yang, Lifei
    Ren, Huanhuan
    Kimata, Jason T.
    Zhou, Paul
    JOURNAL OF VIROLOGY, 2013, 87 (03) : 1899 - 1905
  • [29] Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16
    Marie Pancera
    Syed Shahzad-ul-Hussan
    Nicole A Doria-Rose
    Jason S McLellan
    Robert T Bailer
    Kaifan Dai
    Sandra Loesgen
    Mark K Louder
    Ryan P Staupe
    Yongping Yang
    Baoshan Zhang
    Robert Parks
    Joshua Eudailey
    Krissey E Lloyd
    Julie Blinn
    S Munir Alam
    Barton F Haynes
    Mohammed N Amin
    Lai-Xi Wang
    Dennis R Burton
    Wayne C Koff
    Gary J Nabel
    John R Mascola
    Carole A Bewley
    Peter D Kwong
    Nature Structural & Molecular Biology, 2013, 20 : 804 - 813
  • [30] Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses
    Beltran-Pavez, Carolina
    Bontjer, Ilja
    Gonzalez, Nuria
    Pernas, Maria
    Merino-Mansilla, Alberto
    Olvera, Alex
    Miro, Jose M.
    Brander, Christian
    Alcami, Jose
    Sanders, Rogier W.
    Sanchez-Merino, Victor
    Yuste, Eloisa
    JOURNAL OF VIROLOGY, 2022, 96 (01)